Skip to main content
Year archive

PharmAbcine Inc. — 2019 filings

All 33 regulatory filings released by PharmAbcine Inc. (208340) in 2019, sourced directly from the official regulator.

33 Filings
2019 Period
2019 filings (33)
Filing Released Lang
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2019-12-13 Korean
기업설명회(IR)개최
Regulatory Filings
2019-11-22 Korean
분기보고서 (2019.09)
Interim / Quarterly Report 9M 2019
2019-11-14 Korean
타법인주식및출자증권취득결정
Capital/Financing Update
2019-10-22 Korean
투자판단관련주요경영사항(( TTAC-0001의 재발성 교모세포종 다기관 국제임상(PMC-TTAC-0001_03)에 대한 미국 임상 2상 개시)
Regulatory Filings
2019-09-30 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification
2019-09-27 Korean
전환가액의조정(제1회차)
Capital/Financing Update
2019-09-02 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2019-08-28 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2019-08-28 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2019-08-27 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2019-08-27 Korean
기타경영사항(자율공시)(TTAC-0001의 재발성 교모세포종 다기관 국제 임상 (PMC_TTAC-0001_03)에 대한 호주 2상 임상시험 계획 승인)
Regulatory Filings
2019-08-16 Korean
반기보고서 (2019.06)
Interim / Quarterly Report H1 2019
2019-08-14 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2019-08-07 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2019-07-31 Korean
주식매수선택권행사
Share Issue/Capital Change
2019-07-04 Korean
기타경영사항(특허권취득)(자율공시)(Bispecific Antibody Targeting VEGFR-2 and DLL4, and Pharmaceutical Composition Comprising Thereof)
Regulatory Filings
2019-06-10 Korean
증권발행결과(자율공시)(제1회차)
Capital/Financing Update
2019-05-31 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update
2019-05-29 Korean
조회공시요구(풍문또는보도)(전환사채 발행 추진설)
Regulatory Filings
2019-05-28 Korean
조회공시요구(풍문또는보도)에대한답변(미확정)
Regulatory Filings
2019-05-28 Korean
분기보고서 (2019.03)
Interim / Quarterly Report Q1 2019
2019-05-15 Korean
기업설명회(IR)개최
Regulatory Filings
2019-05-09 Korean
[첨부정정]사업보고서 (2018.12)
Audit Report / Information FY 2018
2019-04-29 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification
2019-04-10 Korean
사업보고서 (2018.12)
Annual Report FY 2018
2019-04-01 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2019-03-28 Korean
감사보고서제출
Audit Report / Information FY 2018
2019-03-20 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2019-03-13 Korean
주주총회집중일개최사유신고
AGM Information
2019-03-12 Korean
주주총회소집결의
AGM Information
2019-03-05 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Management Reports
2019-02-27 Korean
기업설명회(IR)개최
Investor Presentation
2019-02-12 Korean